Oberweis Asset Management Inc Cerus Corp Transaction History

Oberweis Asset Management Inc

  • $2.02 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.38 - $4.22 $247,754 - $309,326
73,300 Added 34.81%
283,900 $1.04 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $49,049 - $83,369
14,300 Added 7.28%
210,600 $758,000
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $14,553 - $18,777
-3,300 Reduced 1.65%
196,300 $1.04 Million
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $271,765 - $394,935
56,500 Added 39.48%
199,600 $1.1 Million
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $685,449 - $955,908
143,100 New
143,100 $871,000

Others Institutions Holding CERS

# of Institutions
160
Shares Held
146M
Call Options Held
48.6K
Put Options Held
8.7K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $253M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email